Shares of Physiomics Plc (LON:PYC – Get Free Report) were down 18% during trading on Wednesday . The stock traded as low as GBX 0.82 ($0.01) and last traded at GBX 0.82 ($0.01). Approximately 13,301,388 shares were traded during trading, an increase of 45% from the average daily volume of 9,156,911 shares. The stock had previously closed at GBX 1 ($0.01).
Physiomics Trading Down 11.2 %
The stock has a market capitalization of £1.80 million, a P/E ratio of -13.83 and a beta of 1.69. The stock’s fifty day moving average price is GBX 0.73 and its two-hundred day moving average price is GBX 0.72.
Insider Buying and Selling
In related news, insider Peter Sargent purchased 459,090 shares of Physiomics stock in a transaction that occurred on Thursday, November 7th. The shares were acquired at an average cost of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,604.81). 4.18% of the stock is owned by corporate insiders.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Further Reading
- Five stocks we like better than Physiomics
- 3 Stocks to Consider Buying in October
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- How to Invest in Insurance Companies: A Guide
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- 3 Warren Buffett Stocks to Buy Now
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
